nominally significantP =.03
Participants in the Sativex group demonstrated a pattern of improved cognitive performance as measured by the QbTest, nominally significant improvements in symptoms of hyperactivity/impulsivity ( P =.03), and trends toward improvement for inattention and emotional lability.